Cancer single-cell dataset platform that maps tumor biology from patient tissue to train models predicting drug response and identifying biomarkers before…
Origin Bio creates patient-derived cancer datasets by collecting FFPE tumor blocks from hospital and biobank partners, annotating regions, and generating matched spatial transcriptomics, H&E imaging, and clinical data for each sample at subcellular resolution. The data captures intra- and inter-tumoral heterogeneity and enables training of models that predict drug response, identify interpretable biomarkers, and use morphology alone to infer spatial gene expression. Pharmaceutical and AI companies license these datasets to stratify patients before enrolling clinical trials, reducing trial size and increasing effect sizes. Origin processes both retrospective and prospective cohorts. Origin is a product of Origin.